Cost-effectiveness of screening asymptomatic women for Chlamydia trachomatis
HEPAC Health Economics in Prevention and Care · 2000
DOI: 10.1007/s101980070003 ↗Kurz gefasst
Fachartikel in der Zeitschrift HEPAC Health Economics in Prevention and Care, 2000. Verfasst von Maarten Postma und 6 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Postma, M., Welte, R., Hoek, A. V. D., Doornum, G. V., Mulder-Folkerts, D., Coutinho, R., & Jager, H. (2000). Cost-effectiveness of screening asymptomatic women for Chlamydia trachomatis. HEPAC Health Economics in Prevention and Care. https://doi.org/10.1007/s101980070003
Vancouver
Postma M, Welte R, Hoek AVD, Doornum GV, Mulder-Folkerts D, Coutinho R, et al. Cost-effectiveness of screening asymptomatic women for Chlamydia trachomatis. HEPAC Health Economics in Prevention and Care. 2000. doi:10.1007/s101980070003
BibTeX
@article{Postma2000,
author = {Postma, Maarten and Welte, Robert and Hoek, Anneke van den and Doornum, Gerard van and Mulder-Folkerts, Dieke and Coutinho, Roel and Jager, Hans},
title = {Cost-effectiveness of screening asymptomatic women for Chlamydia trachomatis},
journal = {HEPAC Health Economics in Prevention and Care},
year = {2000},
doi = {10.1007/s101980070003}
}
EUVIMED